• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Delaying measles vaccination after 15 months may increase seizure risk

byPuja UmaretiyaandCordelia Ross
May 19, 2014
in Infectious Disease, Pediatrics, Public Health
Reading Time: 3 mins read
Share on FacebookShare on Twitter

Image: PD

1. Vaccinations administered in the first year of life were not associated with increased risk of post-vaccination seizures, regardless of whether they were on-time or delayed.

2.  Delaying administration of measles-containing vaccinations after 15 months of age increased risk of post-vaccination seizures compared to on-time vaccination; the highest risk was associated with the measles-mumps-rubella-varicella vaccine (MMRV).

Evidence Rating Level: 3 (Average)        

Study Rundown: More children are receiving delayed vaccinations due to parental intent, lack of health insurance, or other barriers to immunization. This study examined the risk of post-vaccination seizures after the first dose of each vaccine administered in the first two years of life and compared on-time vaccination versus delayed schedule vaccination. Vaccines administered in the first year of life were not significantly associated with seizures, regardless of vaccine type and whether the vaccine was administered on-time or delayed. The measles-mumps-rubella (MMR) vaccine, which is scheduled for administration between 12 to 15 months of age, had a three-fold higher risk of post-vaccination seizure if delayed past 15 months. In children receiving the MMRV vaccine, delayed administration doubled the risk of post-vaccination seizures, compared to the MMR vaccine. This study is limited by analysis that did not account for simultaneous administration of different vaccines. However, these results provide support for on-time vaccination, especially given other known benefits.

Click to read the study published today in Pediatrics

RELATED REPORTS

New Mexico measles outbreak associated with significant costs

Concomitant COVID-19 and influenza vaccination not linked to increased adverse events

Recombinant Zoster Vaccination May Reduce Dementia Risk in Older Adults

Relevant Reading: Effect of age on the risk of fever and seizures following immunization with measles-containing vaccines in children

In-Depth [case-series]:  The Vaccine Safety Datalink was utilized to identify a cohort of 323 247 US children born from 2004-2008. ICD.9 coding was used to identify those that had seizures between age 38 days to 2 years, excluding children with chronic seizure disorders. Among vaccines recommended for administration at 2 months (diphtheria-tetanus-acellular pertussis [DTaP], pneumococcal conjugated vaccine [PCV], haemophilius influenza type B [HIB], inactivated poliovirus [IPV], and rotavirus), there was no association with vaccination and seizures, even with delayed vaccination. The MMR vaccine was associated with increased risk of seizure in the 7 to 10 days post-vaccination (incident risk ratio [IRR] 2.65; 95% CI 1.99-3.55). This risk increased to greater than 6-fold when vaccine administration was delayed past 15 months of age (IRR 6.53; 95% CI 3.15-13.53). The MMRV vaccination was also associated with increased risk of post-vaccination seizure (IRR 4.95; 95% 3.68-6.66), and this risk increased to almost 10-fold when delayed past 15 months (IRR 9.80; 95% CI 4.35-22.06).

More from this author: 65% of alcohol-related childhood vehicular deaths related to riding with drunk drivers; Prenatal SSRI use may increase risk of autism; Roadway design may decrease risk of child pedestrian collisions

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: measlesMMRvaccinationvaccinevaccine schedule
Previous Post

Robust hepatitis B seroprotection in adolescence after immunization in infancy

Next Post

2 Minute Medicine Rewind May 12 – May 19, 2014

RelatedReports

Epidemiologic features of the 2018-2019 measles outbreak in New York City
Infectious Disease

New Mexico measles outbreak associated with significant costs

August 2, 2026
Social networks play key roles in parental vaccination decisions
Infectious Disease

Concomitant COVID-19 and influenza vaccination not linked to increased adverse events

June 29, 2026
Cardiovascular risk factors related to brain volume and associated dementia
Neurology

Recombinant Zoster Vaccination May Reduce Dementia Risk in Older Adults

June 15, 2026
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Cardiology

COVID-19 vaccination is associated with reduced risk of new-onset atrial fibrillation following COVID-19 infection

April 29, 2026
Next Post
New drug for Chagas disease shows antitrypanosomal activity [CHAGASAZOL trial]

2 Minute Medicine Rewind May 12 – May 19, 2014

Mediterranean diet linked to reduced diabetes risk in high risk cardiovascular patients

Less frequent echocardiography for cancer survivors may be more cost effective

High dose antidepressants may increase self-harm risk among children, young adults

USPSTF finds insufficient evidence on screening for suicide risk

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Azacitidine–venetoclax improved event-free survival in induction-eligible AML
  • Bundibugyo Ebola outbreak surpasses 5,700 cases without a validated vaccine
  • Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.

2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in